Navigation Links
BGI partners with Life Technologies to offer sequencing applications on ion torrent
Date:10/21/2013

CARLSBAD, Calif., and Shenzhen, China, October 21, 2013 -- Life Technologies Corporation (NASDAQ: LIFE) and BGI, the world's largest genomics center and service provider, jointly announced that BGI has purchased 38 Ion Proton Sequencers and plans to add at least a dozen more by the end of the year, strengthening the organization's leadership position in the genomics industry. BGI also signed a supply and licensing agreement with Life Technologies, further enhancing BGI's ability to perform basic, agricultural and clinical research.

The addition of the Ion Torrent to BGI's current broad array of technology platforms will facilitate its goal of accelerating and expanding the organization's strong presence in all areas of next-generation sequencing and clinical research, ranging from exome and transcriptome sequencing to aneuploidy testing to whole genome analysis.

BGI has already validated the Ion Proton System in several applications. The Ion Proton Sequencer has consistently delivered over 80 million high-quality sequencing reads in 2-3 hour sequencing runs on the Ion PI Chip in BGI's labs.

"We have been working with the Ion Proton platform on major applications for the last several months and it has passed every test," said Jun Wang, director of BGI. "It is flexible and affordable, so we can quickly deploy it in many satellite labs around the world for all applications. The Ion Proton is also very fast, enabling us to provide our customers and partners results in days, not weeks, which is extremely important for clinical research applications. The upcoming Ion PII Chip is expected to significantly expand sequencing capacity on the same Ion Proton Sequencer and our plan is to migrate additional applications to the Ion Proton platform."

"BGI's commitment to the Ion Proton platform is the ultimate validation that our breakthrough benchtop sequencing technology delivers more value than the big sequencers that have dominated the market for so long," said Mark Stevenson, president and chief operating officer of Life Technologies. "By setting a new standard for speed, simplicity, price and performance, the Ion Proton System has become the choice of the world's largest genomics center, and yet it's still accessible to virtually any lab."

In just three years, Ion Torrent has become the bestselling benchtop sequencer brand in the world by bringing the transformative power of semiconductor technology to sequencing. The Ion Proton Sequencer is just a fraction of the cost of other sequencers to buy and to run, and it delivers sequence in just a few hours, compared to ten days or more for competitors. This makes Ion Torrent technology ideal for both small labs and large-scale platform developer like BGI.


'/>"/>

Contact: Jia Liu
liujia@genomics.cn
BGI Shenzhen
Source:Eurekalert

Related biology news :

1. Medbox Partners with Licensed Medical Cannabis Laboratory and Cultivation Center in Canada
2. BioForce Nanosciences, Inc. Expands Its Global Market. New partnership with Acugenex Limited
3. Genetics Society of America joins editorial partnership for CBE-Life Sciences Education
4. 4 projects awarded Discovery Transformation Grant funding by Minnesota Partnership
5. Newly discovered bacterial partnership changes ocean chemistry
6. Transatlantic partnership to tackle neurodegenerative disease
7. Advance Research Associates Partners With MedNet Solutions
8. NOAA, partners predict possible record-setting deadzone for Gulf of Mexico
9. The DOE Joint Genome Institute expands capabilities via new partnerships
10. TGen and Riddell announce partnership for biomarker study of concussive injuries
11. Capco Partners with EyeLock to Bring Iris Biometric Security to Banks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/13/2016)... 2016  IMPOWER physicians supporting Medicaid patients in ... clinical standard in telehealth thanks to a new partnership ... platform, IMPOWER patients can routinely track key health measurements, ... index, and, when they opt in, share them with ... a local retail location at no cost. By leveraging ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys ... founding CEO, Barrett Bready , M.D., who returned ... of the original technical leadership team, including Chief Technology ... of Product Development, Steve Nurnberg and Vice President of ... to the company. Dr. Bready served as ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... -- Global demand for enzymes is forecast to grow ... billion.  This market includes enzymes used in industrial ... animal feed, and other markets) and specialty applications ... beverages will remain the largest market for enzymes, ... containing enzymes in developing regions.  These and other ...
(Date:6/27/2016)... NC (PRWEB) , ... June 27, 2016 , ... ... mission to bring innovative medical technologies, services and solutions to the healthcare market. ... and implementation of various distribution, manufacturing, sales and marketing strategies that are necessary ...
(Date:6/24/2016)... 2016 Epic Sciences unveiled a liquid ... to PARP inhibitors by targeting homologous recombination deficiency ... new test has already been incorporated into numerous ... types. Over 230 clinical trials are ... including PARP, ATM, ATR, DNA-PK and WEE-1. Drugs ...
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
Breaking Biology Technology: